143 related articles for article (PubMed ID: 24831558)
21. Chronological Review of Endoscopic Indices in Inflammatory Bowel Disease.
Lee JS; Kim ES; Moon W
Clin Endosc; 2019 Mar; 52(2):129-136. PubMed ID: 30130840
[TBL] [Abstract][Full Text] [Related]
22. Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres.
Samaan MA; Pavlidis P; Digby-Bell J; Johnston EL; Dhillon A; Paramsothy R; Akintimehin AO; Medcalf L; Chung-Faye G; DuBois P; Koumoutsos I; Powell N; Anderson SHC; Sanderson J; Hayee BH; Irving PM
Frontline Gastroenterol; 2018 Jul; 9(3):221-231. PubMed ID: 30047549
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Herfarth H; Barnes EL; Valentine JF; Hanson J; Higgins PDR; Isaacs KL; Jackson S; Osterman MT; Anton K; Ivanova A; Long MD; Martin C; Sandler RS; Abraham B; Cross RK; Dryden G; Fischer M; Harlan W; Levy C; McCabe R; Polyak S; Saha S; Williams E; Yajnik V; Serrano J; Sands BE; Lewis JD;
Gastroenterology; 2018 Oct; 155(4):1098-1108.e9. PubMed ID: 29964043
[TBL] [Abstract][Full Text] [Related]
24. Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Narula N; Peerani F; Meserve J; Kochhar G; Chaudrey K; Hartke J; Chilukuri P; Koliani-Pace J; Winters A; Katta L; Shmidt E; Hirten R; Faleck D; Parikh MP; Whitehead D; Boland BS; Singh S; Sagi SV; Fischer M; Chang S; Barocas M; Luo M; Lasch K; Bohm M; Lukin D; Sultan K; Swaminath A; Hudesman D; Gupta N; Shen B; Kane S; Loftus EV; Siegel CA; Sands BE; Colombel JF; Sandborn WJ; Dulai PS
Am J Gastroenterol; 2018 Sep; 113(9):1345. PubMed ID: 29946178
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
Kopylov U; Verstockt B; Biedermann L; Sebastian S; Pugliese D; Sonnenberg E; Steinhagen P; Arebi N; Ron Y; Kucharzik T; Roblin X; Ungar B; Shitrit AB; Ardizzone S; Molander P; Coletta M; Peyrin-Biroulet L; Bossuyt P; Avni-Biron I; Tsoukali E; Allocca M; Katsanos K; Raine T; Sipponen T; Fiorino G; Ben-Horin S; Eliakim R; Armuzzi A; Siegmund B; Baumgart DC; Kamperidis N; Maharshak N; Maaser C; Mantzaris G; Yanai H; Christodoulou DK; Dotan I; Ferrante M
Inflamm Bowel Dis; 2018 Oct; 24(11):2442-2451. PubMed ID: 29788318
[TBL] [Abstract][Full Text] [Related]
26. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
Levine A; Kori M; Kierkus J; Sigall Boneh R; Sladek M; Escher JC; Wine E; Yerushalmi B; Amil Dias J; Shaoul R; Veereman Wauters G; Boaz M; Abitbol G; Bousvaros A; Turner D
Gut; 2019 Feb; 68(2):239-247. PubMed ID: 29420227
[TBL] [Abstract][Full Text] [Related]
28. Zeroing in on endoscopic and histologic mucosal healing to reduce the risk of colorectal neoplasia in inflammatory bowel disease.
Saxena AP; Limdi JK; Farraye FA
Gastrointest Endosc; 2017 Dec; 86(6):1012-1014. PubMed ID: 29146080
[No Abstract] [Full Text] [Related]
29. Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practice.
Bryant RV; Costello SP; Schoeman S; Sathananthan D; Knight E; Lau SY; Schoeman MN; Mountifield R; Tee D; Travis SPL; Andrews JM
J Gastroenterol Hepatol; 2018 Mar; 33(3):599-607. PubMed ID: 28806471
[TBL] [Abstract][Full Text] [Related]
30. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.
Fumery M; Singh S; Dulai PS; Gower-Rousseau C; Peyrin-Biroulet L; Sandborn WJ
Clin Gastroenterol Hepatol; 2018 Mar; 16(3):343-356.e3. PubMed ID: 28625817
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Endoscopic Mucosal Healing of Ulcerative Colitis Using Linked Colour Imaging, a Novel Endoscopic Enhancement System.
Uchiyama K; Takagi T; Kashiwagi S; Toyokawa Y; Tanaka M; Hotta Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Handa O; Konishi H; Kishimoto M; Yagi N; Naito Y; Itoh Y
J Crohns Colitis; 2017 Aug; 11(8):963-969. PubMed ID: 28333209
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis.
Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1248-1255. PubMed ID: 28286194
[TBL] [Abstract][Full Text] [Related]
33. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
Magro F; Gionchetti P; Eliakim R; Ardizzone S; Armuzzi A; Barreiro-de Acosta M; Burisch J; Gecse KB; Hart AL; Hindryckx P; Langner C; Limdi JK; Pellino G; Zagórowicz E; Raine T; Harbord M; Rieder F;
J Crohns Colitis; 2017 Jun; 11(6):649-670. PubMed ID: 28158501
[No Abstract] [Full Text] [Related]
34. ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
Forbes A; Escher J; Hébuterne X; Kłęk S; Krznaric Z; Schneider S; Shamir R; Stardelova K; Wierdsma N; Wiskin AE; Bischoff SC
Clin Nutr; 2017 Apr; 36(2):321-347. PubMed ID: 28131521
[TBL] [Abstract][Full Text] [Related]
35. Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study.
Mallet AL; Bouguen G; Conroy G; Roblin X; Delobel JB; Bretagne JF; Siproudhis L; Peyrin-Biroulet L
Dig Liver Dis; 2017 Mar; 49(3):280-285. PubMed ID: 28089625
[TBL] [Abstract][Full Text] [Related]
36. Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.
Bojic D; Bodger K; Travis S
J Crohns Colitis; 2017 Mar; 11(suppl_2):S576-S585. PubMed ID: 27797917
[TBL] [Abstract][Full Text] [Related]
37. An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis.
Kawalec P; Pilc A
Arch Med Sci; 2016 Oct; 12(5):1097-1109. PubMed ID: 27695502
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Feagan BG; Rubin DT; Danese S; Vermeire S; Abhyankar B; Sankoh S; James A; Smyth M
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):229-239.e5. PubMed ID: 27639327
[TBL] [Abstract][Full Text] [Related]
39. Safety Profile of Biologic Drugs in the Therapy of Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.
Moćko P; Kawalec P; Pilc A
Pharmacotherapy; 2016 Aug; 36(8):870-9. PubMed ID: 27312826
[TBL] [Abstract][Full Text] [Related]
40. Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review.
Penagini F; Dilillo D; Borsani B; Cococcioni L; Galli E; Bedogni G; Zuin G; Zuccotti GV
Nutrients; 2016 Jun; 8(6):. PubMed ID: 27258308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
